Clinical Use Flashcards
most commonly used inotropic agent (other than digoxin) for treating heart failure
Enhance contractility
Dobutamine
*1st choice drug for hyper-triglyceridemia
–Use when low HDL
– For patients with atherosclerotic vascular
disease or diabetes with intolerance to statins
Fibrates
1st line agent for chronic stable angina
Improves glycemic control in
diabetics
Decreases atrial fibrillation
Ranolazine
Acute exudative types of allergy (hay fever, pollinosis) that present with
rhinitis, urticaria, and conjunctivitis
Cetirizine
Fexofenadine
Loratadine
Acute exudative types of allergy (hay fever, pollinosis) that present with
rhinitis, urticaria, and conjunctivitis
i. Prevention of motion sickness
ii. Sedation
Chlorpheniramine
Diphenhydramine
Acute MI (STEMI) 12 hours UA/NSTEMI
Abciximab
Bivalirudin
Acute MI (STEMI) 12 hours
Ticagrelor
Acute MI (STEMI)
tPA; alteplase
Acute MI (STEMI) 12 hours UA/NSTEMI
Heparin
low-molecular-weight heparin
[enoxaparin]
Acute pharyngitis
Penicillin G and V
As an adjunct to diet, niacin is beneficial to patients with
hypercholesterolemia & mixed lipid disorders
Niacin (Vit B3)
asthma; although effective, it is not approved for
treatment of allergic rhinitis
Omalizumab
Atrial fibrillation
Dabigatran
Rivaroxaban
Warfain
blocks nasal discharge (reduces watery nasal secretions)
does not relieve sneezing, itching or nasal congestion
Ipratropium (intranasal)
Community-acquired
pneumonia
Tetracyclines - Doxycycline
Community-acquired
pneumonia
Hospital-acquired
pneumonia
Fluoroquinolone- Levofloxacin
cystic fibrosis
Dornase α
Ivacaftor
Cystic fibrosis P. aeruginosa (with gentamicin)
Piperacillin + tazobactam
Cystic fibrosis P. aeruginosa (with piperacillin)
Aminoglycosides - Gentamicin
decrease afterload
Hydralazine
decrease preload
Furosemide
Isosorbide dinitrate
decrease preload & afterload, and myocardial fibrosis
ACE Inhibitors:
Captopril, Enalapril, Lisinopril
ARBs:
Valsartan
decrease preload & afterload, improves ventricular function
Carvedilol
Metoprolol
decrease preload and myocardial fibrosis
Spironolactone
Distributive shock: alternative inotropic agent used in combination with vasopressor to counteract vasodilation
Cardiogenic shock: lowers the systemic vascular resistance,
adversely affecting coronary perfusion pressure
Dobutamine
Distributive shock: initial vasopressor agents
Cardiogenic shock: improve CO and perfusion pressure, but at
the expense of increasing the HR
Dopamine
Distributive shock: initial vasopressor agents
Cardiogenic shock: increase SVR thus increasing coronary perfusion
Norepinephrine